Is a person with positive HBsAg and anti-HBc (i.e., “HBV surface antigen and core antibody positive”) a carrier?

A patient visited the hospital for hepatitis B testing and was found to be positive for hepatitis B surface antibody (anti-HBs, “item 2”) and hepatitis B core antibody (anti-HBc, “item 5”)—commonly referred to as “HBV 2-5 positive.” Concerned that this result indicated active hepatitis B infection, the patient experienced significant psychological stress. So, does being “HBV 2-5 positive” mean one is a hepatitis B carrier?

Is HBV 2-5 positivity indicative of being a hepatitis B carrier?

No, HBV 2-5 positivity does not indicate being a hepatitis B carrier. This serological pattern suggests prior hepatitis B virus (HBV) infection and current recovery; it reflects the presence of protective anti-HBs antibodies, indicating immunity against HBV. In contrast, a typical “hepatitis B carrier” refers to an individual with persistently normal liver function tests but positive hepatitis B surface antigen (HBsAg, “item 1”) and markedly elevated HBV DNA levels. Generally, asymptomatic carriers do not require specific antiviral therapy but should undergo regular outpatient follow-up.

However, if evidence of active HBV replication or hepatitis flare emerges, prompt antiviral treatment is warranted. Antiviral therapy for chronic hepatitis B effectively suppresses disease progression, improves liver function, and reduces the risks of cirrhosis and hepatocellular carcinoma. Patients are advised to maintain a positive mindset, engage in appropriate physical exercise regularly to strengthen immune function and overall resilience, and undergo comprehensive liver health examinations every six months. Should hepatitis reactivation be detected during screening, targeted treatment is recommended.

Additionally, individuals experiencing symptoms should seek timely medical evaluation at a hospital and follow their physician’s guidance for appropriate management. We hope this information proves helpful to you!